Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B

Chronic hepatitis B (CHB) virus continues to be a leading cause of morbidity and mortality worldwide. The diagnosis of liver fibrosis has a key role in selecting patients with CHB for antiviral treatment. However, serum biomarkers demonstrate limited diagnostic utility. The present study aimed to co...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Exp Ther Med
Glavni autori: Tsuji, Yuki, Namisaki, Tadashi, Kaji, Kosuke, Takaya, Hiroaki, Nakanishi, Keisuke, Sato, Shinya, Saikawa, Soichiro, Sawada, Yasuhiko, Kitagawa, Kou, Shimozato, Naotaka, Kawaratani, Hideto, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2020
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7388477/
https://ncbi.nlm.nih.gov/pubmed/32765655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8798
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items